Disease impacts more than age on operative morbidity in children with Graves' disease after total thyroidectomy

Andreas Machens1, Malik Elwerr1, Rick Schneider1

  • 1Medical Faculty, Department of General, Visceral and Vascular Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Surgery
|September 4, 2018
PubMed

Insights

Total thyroidectomy in children with Graves' disease has low operative morbidity, similar to those with hereditary C-cell disease. Transient hypoparathyroidism is more common in Graves' disease patients but rarely permanent.

Area of Science:

  • Pediatric Surgery
  • Endocrinology
  • Thyroid Disease

Background:

  • Operative morbidity after total thyroidectomy in pediatric Graves' disease is not well-defined.
  • This study compares morbidity in children with Graves' disease to an age-matched cohort with hereditary C-cell disease.

Purpose of the Study:

  • To determine if total thyroidectomy leads to higher operative morbidity in children with Graves' disease, especially younger ones.
  • To compare this morbidity against a control group of children with hereditary C-cell disease.

Main Methods:

  • Retrospective analysis of 58 children with Graves' disease and 108 with hereditary C-cell disease.
  • Comparison of operative morbidity, including mortality, hypoparathyroidism, nerve palsy, and wound complications, across age groups.

Main Results:

  • No significant difference in operative mortality between the two groups.
  • Children with Graves' disease had a higher risk of transient hypoparathyroidism (29% vs. 17%).
  • Permanent hypoparathyroidism, nerve palsy, hemorrhage, and infections were rare and generally resolved.

Conclusions:

  • Disease type, rather than age, influences operative morbidity in pediatric total thyroidectomy for Graves' disease.
  • Overall morbidity is low, and permanent complications are infrequent in experienced surgical centers.
Abstract

Related Concept Videos

The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...